thiourea and 2-4-thiazolidinedione

thiourea has been researched along with 2-4-thiazolidinedione* in 2 studies

Other Studies

2 other study(ies) available for thiourea and 2-4-thiazolidinedione

ArticleYear
Urea/thiourea: efficient, inexpensive and reusable catalysts for the synthesis of pyrazole derivatives with 2-iminothiazolidin-4-one and 2,4-thiazolidinediones under solvent-free conditions.
    Molecular diversity, 2017, Volume: 21, Issue:2

    An efficient and green synthesis of pyrazolyl-2,4-thiazolidinediones/pyrazolyl-2-iminothiazolidine-4-ones 7(a-j) has been developed using urea/thiourea as catalyst. Two methods (A and B) have been introduced for the synthesis of these compounds. Method A performed well for the condensation of pyrazole-4-carboxaldehydes 4(a-e) with 2-iminothiazolidin-4-one 5a and with 2,4-thiazolidinedione 5b at 110 [Formula: see text] for 16-20 min to furnish (Z)-5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)thiazolidine-2,4-diones 7(a-j) in excellent yields. In method B, the pyrazole-4-carboxaldehydes 4(a-e) were condensed with urea/thiourea at 110 [Formula: see text] for 10 min to give key intermediates 6(a-j) which were later condensed with 5a and 5b to afford 7(a-j) via the elimination of urea/thiourea rather than the formation of a Biginelli product. These two protocols are inexpensive, eco-friendly and high yielding to provide the final products. The synthesis of compound 7f.

    Topics: Catalysis; Chemistry Techniques, Synthetic; Costs and Cost Analysis; Pyrazoles; Thiazoles; Thiazolidinediones; Thiourea

2017
Synthesis of novel thiourea, thiazolidinedione and thioparabanic acid derivatives of 4-aminoquinoline as potent antimalarials.
    Bioorganic & medicinal chemistry letters, 2009, May-01, Volume: 19, Issue:9

    In search of new 4-aminoquinolines which are not recognized by CQR mechanism, thiourea, thiazolidinedione and thioparabanic acid derivatives of 4-aminoquinoline were synthesized and screened for their antimalarial activities. Thiourea derivative 3 found to be the most active against CQ sensitive strain 3D7 of Plasmodium falciparum in an in vitro model with an IC(50) of 6.07ng/mL and also showed an in vivo suppression of 99.27% on day 4 against CQ resistant strain N-67 of Plasmodium yoelii.

    Topics: Aminoquinolines; Animals; Antimalarials; Chemistry, Pharmaceutical; Chlorocebus aethiops; Chloroquine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Plasmodium falciparum; Plasmodium yoelii; Thiazolidinediones; Thiourea; Vero Cells

2009